MyAverix Finance
US · Healthcare
Burzynski Research (BZYR)
Biotechnology
Burzynski Research (BZYR) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BZYR
Burzynski Research (BZYR) — FAQ
What is BZYR's P/E ratio?
The price-to-earnings (P/E) ratio for Burzynski Research (BZYR) is 18.00 (data as of 2026-03-23).
Does Burzynski Research pay a dividend?
Dividend yield is not available in the current snapshot for Burzynski Research (BZYR). Check the MyAverix Finance app for the latest dividend data.
What sector is Burzynski Research in?
Burzynski Research (BZYR) is classified in the Healthcare sector (Biotechnology industry).
What exchange is BZYR listed on?
BZYR is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.